Colgate-Palmolive (NYSE:CL) Shares Acquired by Integrated Investment Consultants LLC

Integrated Investment Consultants LLC grew its stake in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 369.4% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 13,566 shares of the company's stock after buying an additional 10,676 shares during the period. Integrated Investment Consultants LLC's holdings in Colgate-Palmolive were worth $1,408,000 at the end of the most recent reporting period.

Other hedge funds also recently made changes to their positions in the company. E Fund Management Hong Kong Co. Ltd. bought a new stake in Colgate-Palmolive during the 2nd quarter valued at approximately $25,000. Continuum Advisory LLC lifted its stake in shares of Colgate-Palmolive by 46.5% in the 2nd quarter. Continuum Advisory LLC now owns 394 shares of the company's stock valued at $38,000 after purchasing an additional 125 shares during the last quarter. Reston Wealth Management LLC bought a new position in shares of Colgate-Palmolive during the 3rd quarter valued at approximately $42,000. Capital Performance Advisors LLP purchased a new stake in Colgate-Palmolive during the 3rd quarter valued at $53,000. Finally, Prospera Private Wealth LLC bought a new stake in Colgate-Palmolive in the third quarter worth $64,000. 80.41% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

CL has been the topic of several recent analyst reports. Wells Fargo & Company reduced their target price on shares of Colgate-Palmolive from $100.00 to $92.00 and set an "underweight" rating on the stock in a research note on Monday, October 28th. HSBC restated a "hold" rating on shares of Colgate-Palmolive in a research report on Friday, July 26th. Jefferies Financial Group downgraded Colgate-Palmolive from a "buy" rating to a "hold" rating and reduced their price target for the stock from $103.00 to $95.00 in a report on Wednesday, July 24th. Morgan Stanley boosted their price objective on Colgate-Palmolive from $103.00 to $111.00 and gave the company an "overweight" rating in a report on Monday, July 29th. Finally, Deutsche Bank Aktiengesellschaft lowered Colgate-Palmolive from a "buy" rating to a "hold" rating and increased their target price for the stock from $107.00 to $109.00 in a research note on Monday, September 9th. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and thirteen have given a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $105.11.

Insider Buying and Selling

In related news, CFO Stanley J. Sutula III sold 45,410 shares of the firm's stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the transaction, the chief financial officer now owns 36,726 shares in the company, valued at $3,456,283.86. This trade represents a 55.29 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Martina Hundmejean sold 2,313 shares of the business's stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $103.86, for a total value of $240,228.18. Following the sale, the director now owns 11,755 shares in the company, valued at approximately $1,220,874.30. The trade was a 16.44 % decrease in their position. The disclosure for this sale can be found here. 0.34% of the stock is owned by company insiders.

Colgate-Palmolive Stock Up 0.5 %

Shares of Colgate-Palmolive stock traded up $0.46 on Thursday, reaching $94.37. The stock had a trading volume of 2,339,004 shares, compared to its average volume of 4,386,980. Colgate-Palmolive has a 1 year low of $75.50 and a 1 year high of $109.30. The company has a 50 day moving average price of $98.56 and a 200 day moving average price of $98.52. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46. The stock has a market capitalization of $77.10 billion, a P/E ratio of 26.91, a P/E/G ratio of 3.34 and a beta of 0.42.

Colgate-Palmolive Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were given a $0.50 dividend. The ex-dividend date was Friday, October 18th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.12%. Colgate-Palmolive's payout ratio is 57.31%.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.